Researchers made small tweaks to the molecular structure of LSD to see if it could be turned into an effective brain-healing ...

Research, with promising results, was widespread at VA hospitals and other institutions until the late 1960s, when moral ...

Get Healthy. Psychedelics are coming out of the closet and into the mainstream, even demonstrating some potential medical ...

New research published in the journal Neuropharmacology has found that low doses of a psychedelic drug called DOPR ...

Psychosis involves complex brain interactions, from neurotransmitter imbalances to genetic risks. Understanding its biology ...

If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...

Among the other weird things it's done, the CIA once tried to mind-control a crime boss by giving him loads of LSD.

Swinburne University of Technology is part of a global team working to treat psychosis via new therapies targeting disorganisation in a world-first approach. (supplied) 475210_01 Swinburne University ...

‘There are many non-hallucinogenic analogues of LSD, but the fundamental difference is that all of those compounds are very ...

Depression, schizophrenia and other mental health conditions affect 1 in 4 people in their lifetime, but the mechanisms underlying these conditions are poorly understood. New research led by ...

“This discovery of the ADPN provides a critical tool for advancing our understanding and management of psychosis in Alzheimer’s disease,” said Dr. Koppel. “This biomarker can potentially ...

MERIT is one of several metacognitive psychotherapies, designed especially to meet the needs of individuals living with serious mental illnesses, including schizophrenia. It is deliverable in both ...